The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
12
2 IV injection of \~11 mCi (total) F-18 labeled compound
UCLA Medical Center
Los Angeles, California, United States
John Hopkins University
Baltimore, Maryland, United States
Dosimetry analysis following whole body imaging after stress injection
Time frame: Imaging takes place approximately 0 - 300 minutes post injection
Safety analysis following vital signs, ECGs, EEG, neuro and physical exams, telephone and visit follow up, and blood draws for chemistry and hematology post injection of BMS747158 at rest and stress
Time frame: Screening (14 days prior to dosing) through 14 days post dose administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.